Minichromosome maintenance protein 5 is an important pathogenic factor of oral squamous cell carcinoma

Hao,Miao; Hao,Miao; Wang,Huiyu; Wang,Huiyu; Zhang,Chu; Zhang,Chu; Li,Chunyan; Li,Chunyan; Wang,Xiaofeng; Wang,Xiaofeng

doi:10.3892/ol.2020.11970

Minichromosome maintenance protein 5 is an important pathogenic factor of oral squamous cell carcinoma

Authors:
- Miao Hao
- Huiyu Wang
- Chu Zhang
- Chunyan Li
- Xiaofeng Wang
View Affiliations

Affiliations: Scientific Research Center, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China, Department of Stomatology, China‑Japan Union Hospital of Jilin University, Changchun, Jilin 130033, P.R. China
Published online on: August 10, 2020 https://doi.org/10.3892/ol.2020.11970
Article Number: 109
Copyright: © Hao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Oral squamous cell carcinoma is one of the most common causes of malignancy‑associated death. Early diagnosis of oral squamous cell carcinoma (OSCC) is important in patient treatment and prognostic evaluation. Due to the lack of significant therapeutic benefit, the 5‑year survival rate has not improved. Therefore, effective novel markers are needed to improve diagnosis. To determine novel promising diagnostic biomarkers for OSCC, 416 upregulated and 416 downregulated differentially expressed genes were screened from OSCC tissues using an RNA microarray. The results suggested that minichromosome maintenance protein (MCM5) mRNA was significantly overexpressed in OSCC tissues compared with that in adjacent normal tissues. Moreover, silencing of MCM5 expression an OSCC cell line (SCC‑15) significantly impaired proliferation and colony formation. Furthermore, negative regulation of the mRNA and protein expression of MCM5 and demonstrated that MCM5 served as a cancer‑promoting gene modulating OSCC cell proliferation through induced G₂/M phase arrest. In this process, the mRNA expression of cyclin E and cyclin‑dependent kinase 2 was downregulated, while p21 expression was upregulated. These results suggested that MCM5 may be an important pathogenic factor of OSCC. High expression levels of MCM5 may serve as a marker for the early diagnosis of OSCC.

View Figures

View References

1	Ruicci KM, Meens J, Sun RX, Rizzo G, Pinto N, Yoo J, Fung K, MacNeil D, Mymryk JS, Barrett JW, et al: A controlled trial of HNSCC patient-derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth. Int J Cancer. 145:2100–2106. 2019. View Article : Google Scholar : PubMed/NCBI
2	Khurshid Z, Zafar MS, Khan RS, Najeeb S, Slowey PD and Rehman IU: Role of salivary biomarkers in oral cancer detection. Adv Clin Chem. 86:23–70. 2018. View Article : Google Scholar : PubMed/NCBI
3	Thomson PJ: Perspectives on oral squamous cell carcinoma prevention-proliferation, position, progression and prediction. J Oral Pathol Med. 47:803–807. 2018. View Article : Google Scholar : PubMed/NCBI
4	Sim F, Leidner R and Bell RB: Immunotherapy for Head and Neck cancer. Oral Maxillofac Surg Clin North Am. 31:85–100. 2019. View Article : Google Scholar : PubMed/NCBI
5	Yao Y, Chen X, Lu S, Zhou C, Xu G, Yan Z, Yang J, Yu T, Chen W, Qian Y, et al: Circulating long noncoding rnas as biomarkers for predicting head and neck squamous cell carcinoma. Cell Physiol Biochem. 50:1429–1440. View Article : Google Scholar : PubMed/NCBI
6	Long T, Liu Z, Zhou X, Yu S, Tian H and Bao Y: Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis. Mol Med Rep. 19:2020–2040. 2019.
7	Lei B, Zhang XY, Zhou JP, Mu GN, Li YW, Zhang YX and Pang D: Transcriptome sequencing of HER2-positive breast cancer stem cells identifies potential prognostic marker. Tumour Biol. 37:14757–14764. 2016. View Article : Google Scholar : PubMed/NCBI
8	Zhu L, Guo Q, Jin S, Feng H, Zhuang H, Liu C, Tan M, Liu J, Li X and Lin B: Analysis of the gene expression profile in response to human epididymis protein 4 in epithelial ovarian cancer cells. Oncol Rep. 36:1592–1604. 2016. View Article : Google Scholar : PubMed/NCBI
9	Xie C, Xu M, Lu D, Zhang W, Wang L, Wang H, Li J, Ren F and Wang C: Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles. Mol Med Rep. 18:2715–2723. 2018.PubMed/NCBI
10	Chen Y, Hennessy KM, Botstein D and Tye BK: CDC46/MCM5, a yeast protein whose subcellular localization is cell cycle-regulated, is involved in DNA replication at autonomously replicating sequences. Proc Natl Acad Sci USA. 89:10459–10463. 1992. View Article : Google Scholar : PubMed/NCBI
11	Su Z, Zheng X, Zhang X, Wang Y, Zhu S, Lu F, Qu J and Hou L: Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5. J Dermatol Sci. 85:216–225. 2017. View Article : Google Scholar : PubMed/NCBI
12	Zhong H, Chen B, Neves H, Xing J, Ye Y, Lin Y, Zhuang G, Zhang SD, Huang J and Kwok HF: Expression of minichromosome maintenance genes in renal cell carcinoma. Cancer Manag Res. 9:637–647. 2017. View Article : Google Scholar : PubMed/NCBI
13	Liao X, Han C, Wang X, Huang K, Yu T, Yang C, Huang R, Liu Z, Han Q and Peng T: Prognostic value of minichromosome maintenance mRNA expression in early-stage pancreatic ductal adenocarcinoma patients after pancreaticoduodenectomy. Cancer Manag Res. 10:3255–3271. 2018. View Article : Google Scholar : PubMed/NCBI
14	Wang D, Li Q, Li Y and Wang H: The role of MCM5 expression in cervical cancer: Correlation with progression and prognosis. Biomed Pharmacother. 98:165–172. 2018. View Article : Google Scholar : PubMed/NCBI
15	Liu H, Takeuchi S, Moroi Y, Lin N, Urabe K, Kokuba H, Imafuku S, Dainichi T, Uchi H, Furue M and Tu Y: Expression of minichromosome maintenance 5 protein in proliferative and malignant skin diseases. Int J Dermatol. 46:1171–1176. 2007. View Article : Google Scholar : PubMed/NCBI
16	Liao X, Liu X, Yang C, Wang X, Yu T, Han C, Huang K, Zhu G, Su H, Qin W, et al: Distinct diagnostic and prognostic values of minichromosome maintenance gene expression in patients with hepatocellular carcinoma. J Cancer. 9:2357–2373. 2018. View Article : Google Scholar : PubMed/NCBI
17	Yu SY, Wang YP, Chang JY, Shen WR, Chen HM and Chiang CP: Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma. J Oral Pathol Med. 43:344–349. 2014. View Article : Google Scholar : PubMed/NCBI
18	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
19	Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao QL, Wu W and Wu XZ: MiR-223 suppresses cell proliferation by targeting IGF-1R. PLoS One. 6:e270082011. View Article : Google Scholar : PubMed/NCBI
20	Saleem M, Asif J, Asif M and Saleem U: Amygdalin from apricot kernels induces apoptosis and causes cell cycle arrest in cancer cells: An updated review. Anticancer Agents Med Chem. 18:1650–1655. 2018. View Article : Google Scholar : PubMed/NCBI
21	Seo YS and Kang YH: The Human replicative helicase, the CMG Complex, as a target for anti-cancer therapy. Front Mol Biosci. 5:262018. View Article : Google Scholar : PubMed/NCBI
22	Everson M, Magee C, Alzoubaidi D, Brogden S, Graham D, Lovat LB, Novelli M and Haidry R: Minichromosomal maintenance component complex 5 (MCM5) as a marker of barrett's esophagus-related neoplasia: A feasibility study. Dig Dis Sci. 64:2815–2822. 2019. View Article : Google Scholar : PubMed/NCBI
23	Margalit DN and Lin A: Two sides of the same coin: Head and neck cancer treatment De-Intensification and intensification with induction chemotherapy. Int J Radiat Oncol Biol Phys. 102:1–4. 2018. View Article : Google Scholar : PubMed/NCBI
24	Mio C, Lavarone E, Conzatti K, Baldan F, Toffoletto B, Puppin C, Filetti S, Durante C, Russo D, Orlacchio A, et al: MCM5 as a target of BET inhibitors in thyroid cancer cells. Endocr Relat Cancer. 23:335–347. 2016. View Article : Google Scholar : PubMed/NCBI
25	Gakiopoulou H, Korkolopoulou P, Levidou G, Thymara I, Saetta A, Piperi C, Givalos N, Vassilopoulos I, Ventouri K, Tsenga A, et al: Minichromosome maintenance proteins 2 and 5 in non-benign epithelial ovarian tumours: Relationship with cell cycle regulators and prognostic implications. Br J Cancer. 97:1124–1134. 2007. View Article : Google Scholar : PubMed/NCBI
26	Kelly JD, Dudderidge TJ, Wollenschlaeger A, Okoturo O, Burling K, Tulloch F, Halsall I, Prevost T, Prevost AT, Vasconcelos JC, et al: Bladder cancer diagnosis and identification of clinically significant disease by combined urinary detection of Mcm5 and nuclear matrix protein 22. PLoS One. 7:e403052012. View Article : Google Scholar : PubMed/NCBI
27	Chen X, Scapa JE, Liu DX and Godbey WT: Cancer-specific promoters for expression-targeted gene therapy: Ran, brms1 and mcm5. J Gene Med. 18:89–101. 2016. View Article : Google Scholar : PubMed/NCBI
28	Wang D, Wang H, Li Y and Li Q: MiR-362-3p functions as a tumor suppressor through targeting MCM5 in cervical adenocarcinoma. Biosci Rep. 38:BSR201806682018. View Article : Google Scholar : PubMed/NCBI
29	Janardhan K, Jensen H, Clayton NP and Herbert RA: Immunohistochemistry in investigative and toxicologic pathology. Toxicol Pathol. 46:488–510. 2018. View Article : Google Scholar : PubMed/NCBI
30	Hua C, Zhao G, Li Y and Bie L: Minichromosome maintenance (MCM) Family as potential diagnostic and prognostic tumor markers for human gliomas. BMC Cancer. 14:5262014. View Article : Google Scholar : PubMed/NCBI
31	Majid S, Dar AA, Saini S, Chen Y, Shahryari V, Liu J, Zaman MS, Hirata H, Yamamura S, Ueno K, et al: Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. Cancer Res. 70:2809–2818. 2010. View Article : Google Scholar : PubMed/NCBI
32	Das M, Prasad SB, Yadav SS, Govardhan HB, Pandey LK, Singh S, Pradhan S and Narayan G: Over expression of minichromosome maintenance genes is clinically correlated to cervical carcinogenesis. PLoS One. 8:e696072013. View Article : Google Scholar : PubMed/NCBI
33	Issac MSM, Yousef E, Tahir MR and Gaboury LA: MCM2, MCM4, and MCM6 in breast cancer: Clinical utility in diagnosis and prognosis. Neoplasia. 21:1015–1035. 2019. View Article : Google Scholar : PubMed/NCBI
34	Giaginis C, Georgiadou M, Dimakopoulou K, Tsourouflis G, Gatzidou E, Kouraklis G and Theocharis S: Clinical significance of MCM-2 and MCM-5 expression in colon cancer: Association with clinicopathological parameters and tumor proliferative capacity. Dig Dis Sci. 54:282–291. 2009. View Article : Google Scholar : PubMed/NCBI
35	Liu YZ, Wang BS, Jiang YY, Cao J, Hao JJ, Zhang Y, Xu X, Cai Y and Wang MR: MCMs expression in lung cancer: Implication of prognostic significance. J Cancer. 8:3641–3647. 2017. View Article : Google Scholar : PubMed/NCBI
36	Korkolopoulou P, Givalos N, Saetta A, Goudopoulou A, Gakiopoulou H, Thymara I, Thomas-Tsagli E and Patsouris E: Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: A multivariate survival study including proliferation markers and cell cycle regulators. Hum Pathol. 36:899–907. 2005. View Article : Google Scholar : PubMed/NCBI
37	Passerini V, Ozeri-Galai E, de Pagter MS, Donnelly N, Schmalbrock S, Kloosterman WP, Kerem B and Storchová Z: The presence of extra chromosomes leads to genomic instability. Nat Commun. 7:107542016. View Article : Google Scholar : PubMed/NCBI
38	Aparicio T, Guillou E, Coloma J, Montoya G and Méndez J: The human GINS complex associates with Cdc45 and MCM and is essential for DNA replication. Nucleic Acids Res. 37:2087–2095. 2009. View Article : Google Scholar : PubMed/NCBI PubMed/NCBI PubMed/NCBI PubMed/NCBI